First Manhattan CO Haleon PLC Transaction History

First Manhattan CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$8.02 - $8.67 $4,250 - $4,595	-530 Reduced 6.17%	8,065 $68,000
Q4 2023 Feb 13, 2024	SELL	$7.78 - $8.62 $6,737 - $7,464	-866 Reduced 9.15%	8,595 $70,000
Q3 2023 Nov 14, 2023	SELL	$7.85 - $8.94 $43,104 - $49,089	-5,491 Reduced 36.72%	9,461 $78,000
Q2 2023 Aug 14, 2023	SELL	$8.04 - $9.0 $15,058 - $16,857	-1,873 Reduced 11.13%	14,952 $125,000
Q1 2023 May 15, 2023	SELL	$7.57 - $8.37 $8,296 - $9,173	-1,096 Reduced 6.12%	16,825 $136,000
Q4 2022 Feb 14, 2023	BUY	$5.96 - $8.06 $3,254 - $4,400	546 Added 3.14%	17,921 $143,000
Q3 2022 Nov 14, 2022	BUY	$5.63 - $7.5 $97,821 - $130,312	17,375 New	17,375 $105,000

639

412M

149K

16K

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $44.8B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.